"The voice for cancer physicians and their patients in Massachusetts."

  • 16 Dec 2019 2:01 PM | Nathan Strunk (Administrator)

    The Centers for Medicare and Medicaid Services (CMS) has assigned a permanent J-code for Polivy (polatuzumab vedotin-piiq; Genentech). Effective January 1, 2020, the J-code is J9309 (Injection, polatuzumab vedotin-piiq, 1 mg). 

Upcoming events

Massachusetts Society of Clinical Oncologists (c)

P.O. Box 549154, Waltham, MA, 02454
t: 781.434.7329 | f: 781.464.4896 |email: nstrunk@mms.org
Powered by Wild Apricot Membership Software